Skp2 and Skp2B team up against Rb and p53.
Open Access
- 1 January 2011
- journal article
- Published by Springer Science and Business Media LLC in Cell Division
- Vol. 6 (1), 1
- https://doi.org/10.1186/1747-1028-6-1
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Skp2 Suppresses p53-Dependent Apoptosis by Inhibiting p300Molecular Cell, 2008
- Androgens target prohibitin to regulate proliferation of prostate cancer cellsOncogene, 2004
- Estrogens Down-regulate p27 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK PathwayJournal of Biological Chemistry, 2003
- Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repressionOncogene, 2002
- Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growthThe EMBO Journal, 2002
- Skp2 is oncogenic and overexpressed in human cancersProceedings of the National Academy of Sciences of the United States of America, 2001
- An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogensProceedings of the National Academy of Sciences of the United States of America, 1999
- Reconstitution of G 1 Cyclin Ubiquitination with Complexes Containing SCF Grr1 and Rbx1Science, 1999
- SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-BoxCell, 1996
- p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21Cell, 1994